Making It Personal: Neoantigen Vaccines in Metastatic Melanoma
- PMID: 28813655
- DOI: 10.1016/j.immuni.2017.08.001
Making It Personal: Neoantigen Vaccines in Metastatic Melanoma
Abstract
Somatic mutations in cancer can be translated into peptides, termed neoantigens, which can be recognized by the immune system as "foreign" epitopes. Two recent studies in Nature (Sahin et al., 2017; Ott et al., 2017) examine the effects of neoantigen vaccines on patients with stage III or IV melanoma and demonstrate immunogenicity and intriguing clinical safety and efficacy data in phase I studies.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
An immunogenic personal neoantigen vaccine for patients with melanoma.Nature. 2017 Jul 13;547(7662):217-221. doi: 10.1038/nature22991. Epub 2017 Jul 5. Nature. 2017. PMID: 28678778 Free PMC article. Clinical Trial.
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.Nature. 2017 Jul 13;547(7662):222-226. doi: 10.1038/nature23003. Epub 2017 Jul 5. Nature. 2017. PMID: 28678784
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical